Clinical Innovation FUSMobile is developing image-guided focused ultrasound technologies and Neurolyser XR for non-invasive chronic pain treatment, presenting a target for healthcare device partnerships, clinical collaboration, and potential deployment in pain management programs.

Event Presence Active outreach at ASPN 2026 and related conferences indicates opportunities for lead generation, trials, and speaking engagements to position Neurolyser XR with key pain and neuroscience stakeholders.

Technology Stack Leveraging cloud, collaboration, and web platforms (Google Cloud, Google Workspace, Wix/WordPress) suggests potential for scaled customer-facing demos, telemedicine integration, and digital marketing partnerships to boost awareness and sales.

Growth Potential Revenue in the low millions with a focused team and eleven-year development window signals readiness for strategic partnerships, early-adopter programs, and physician office or clinic channel partnerships to accelerate adoption.

Sustainability & Impact Non-invasive, image-guided therapy aligns with reducing surgical risk and recovery times, offering a value proposition for healthcare providers focused on patient safety, cost containment, and improved outcomes in chronic pain management.